1. HIV infection and COVID-19: risk factors for severe disease
- Author
-
Dorsaf Slama, Dominique Salmon, M. Karmochkine, Patricia Brazille, Florence Canoui-Poitrine, Laurence Weiss, Rafael Usubillaga, Nicolas Etienne, Jean Paul Viard, Dominique Batisse, Valerie Anne Letembet, Hassan Joumaa, Etienne Canouï, Laurence Slama, L. Segaux, and Juliette Pavie
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Multivariate analysis ,Pneumonia, Viral ,Immunology ,HIV Infections ,Ethnic origin ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Metabolic Diseases ,Risk Factors ,Internal medicine ,Pandemic ,medicine ,Humans ,Immunology and Allergy ,Prospective Studies ,030212 general & internal medicine ,Prospective cohort study ,Pandemics ,Africa South of the Sahara ,business.industry ,Metabolic disorder ,COVID-19 ,Middle Aged ,medicine.disease ,CD4 Lymphocyte Count ,Pneumonia ,Logistic Models ,030104 developmental biology ,Infectious Diseases ,Anti-Retroviral Agents ,Multivariate Analysis ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Clinical Science: Special Section: Covid-19 among People Living with HIV ,Female ,Observational study ,France ,Coronavirus Infections ,Risk assessment ,business - Abstract
Supplemental Digital Content is available in the text, We performed an observational prospective monocentric study in patients living with HIV (PLWH) diagnosed with COVID-19. Fifty-four PLWH developed COVID-19 with 14 severe (25.9%) and five critical cases (9.3%), respectively. By multivariate analysis, age, male sex, ethnic origin from sub-Saharan Africa and metabolic disorder were associated with severe or critical forms of COVID-19. Prior CD4+ T cell counts did not differ between groups. No protective effect of a particular antiretroviral class was observed.
- Published
- 2020
- Full Text
- View/download PDF